FOSL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Fossil Group (FOSL) is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. While the stock is deeply oversold and there is some analyst optimism on a turnaround, the current setup still shows weak trend quality, no strong proprietary buy signal, and declining revenue. For an inpatient investor who does not want to wait for an ideal entry, this is still more of a hold than an immediate buy.
Technically, FOSL is weak but oversold. RSI_6 at 16.974 suggests the stock is extremely oversold, which can support a short-term bounce. However, MACD histogram is -0.14 and negatively expanding, indicating downside momentum is still active. Moving averages are converging, which hints at possible stabilization, but price is sitting near key support around 4.44 with current pre-market price at 4.51, just above S1. Resistance is nearby at 5.00 pivot and 5.56 R1. The stock trend data also suggests limited upside in the very near term, with only modest expected gains over the next week and month.
["RSI is deeply oversold, increasing the chance of a technical rebound.", "Analyst sentiment has improved, with Buy/Outperform ratings and $7 price targets from Maxim and Northland.", "Q4 sales beat and FY26 revenue guidance came in above expectations.", "Gross margin improved to 57.39%, showing some operational improvement.", "News around the BIG TIC spring campaign and InMobi's omnichannel ad solution may support brand awareness and marketing effectiveness."]
["Q4 2025 revenue fell 18.05% YoY, showing the business is still shrinking.", "Net income remains negative at -18.56M and EPS is still negative.", "MACD is bearish and weakening, so downside momentum has not fully reversed.", "No strong insider or hedge fund accumulation signal.", "No AI Stock Picker or SwingMax buy signal today.", "No congress trading data or influential buyer activity to support conviction."]
In Q4 2025, Fossil posted revenue of 280.5M, down 18.05% year over year, which is the biggest concern. The company did improve on profitability trends: net income loss narrowed to -18.56M, EPS improved to -0.33, and gross margin expanded to 57.39%. The latest quarter season is Q4 2025. Overall, the quarter shows better margins and less bottom-line damage, but the top line is still under pressure, so the turnaround is not yet fully proven.
Recent analyst tone has turned more constructive. On 2026-02-19, Northland initiated coverage with an Outperform rating and a $7 price target. On 2026-03-12, Maxim raised its target to $7 from $5 and kept a Buy rating after a Q4 sales beat and FY26 guidance above expectations. The Wall Street pros view is cautiously positive: analysts see turnaround potential and improving execution, but the market still lacks confirmation from sustained revenue growth and stronger price action.
